WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016086222) ADJUVANT COMPOSITIONS AND RELATED METHODS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/086222    International Application No.:    PCT/US2015/062836
Publication Date: 02.06.2016 International Filing Date: 27.11.2015
IPC:
A61K 39/00 (2006.01), A61K 45/00 (2006.01), A61K 47/00 (2006.01)
Applicants: VAXLIANT, LLC [US/US]; 421 W. Industrial Drive Lincoln, Nebraska 68528 (US)
Inventors: MILLER, Timothy J.; (US).
PFANNENSTIEL, Mary Ann; (US)
Agent: TRUITT, Tracey; (US)
Priority Data:
62/084,698 26.11.2014 US
62/137,659 24.03.2015 US
Title (EN) ADJUVANT COMPOSITIONS AND RELATED METHODS
(FR) COMPOSITIONS D’ADJUVANT ET PROCÉDÉS ASSOCIÉS
Abstract: front page image
(EN)The present disclosure provides for an adjuvant composition that is suited for injectable as well as transdermal administration. The adjuvant composition generally comprises a lipophile, a polymer of acrylic or methacrylic acid, saline, cholesterol, a saponin, and sodium hydroxide. A vaccine composition is also provided for that generally includes the vaccine composition of the present disclosure and an antigen. A method for vaccinating animals and humans utilizing the adjuvant composition of the present disclosure is also provided.
(FR)La présente invention concerne une composition d'adjuvant qui est adaptée pour un injectable ainsi qu’une administration transdermique. La composition d’adjuvant comprend généralement un lipophile, un polymère d'acide acrylique ou méthacrylique, une solution saline, du cholestérol, une saponine, et de l’hydroxyde de sodium. L’invention concerne en outre une composition de vaccin qui comprend généralement la composition du vaccin de la présente invention et un antigène. L'invention concerne en outre un procédé pour la vaccination d'animaux et d’humains utilisant la composition d'adjuvant de la présente invention.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)